Pfizer temporarily reducing the supply of its Covid-19 vaccine in Europe

- Commercial -

Well being officers of Norway mentioned on Friday – That US Pharmaceutical Firm Pfizer goes to scale back the availability of its Covid-19 Vaccine in Europe. As a result of the corporate needs to extend the availability capability of its Corona Vaccine.

The Director of the an infection management division mentioned – “We have received this message today by Company side”. They mentioned – “We said that we need 43.875 doses of their vaccine in the upcoming three weeks, but now it seems we will get only 36,075 doses of Pfizer vaccine”

Additionally Learn: The French well being ministry will pace up the Covid-19 vaccination marketing campaign

It mentioned, “All European countries will be affected by this temporary reduction.” Norway will not be a part of the European Union. Nevertheless, neither Pfizer nor its German associate BioNotech has but confirmed the availability shortfall.

- Commercial -